Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway

Recent studies have suggested that dipeptidyl peptidase 4 (DPP4) inhibitors increase the risk of development of bullous pemphigoid (BP), which is the most common autoimmune blistering skin disease; however, the associated mechanisms remain unclear, and thus far, no therapeutic targets responsible fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozawa, Keisuke, Suzuki, Takahide, Kayanuma, Gen, Yamamoto, Hiroki, Nagayasu, Kazuki, Shirakawa, Hisashi, Kaneko, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849361/
https://www.ncbi.nlm.nih.gov/pubmed/36685490
http://dx.doi.org/10.3389/fimmu.2022.1084960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849361/
https://www.ncbi.nlm.nih.gov/pubmed/36685490
http://dx.doi.org/10.3389/fimmu.2022.1084960

Ejemplares similares